Categories Earnings, Health Care, LATEST, Technology

Earnings: Dentsply Sirona Q4 profit beats despite revenue drop; stock jumps

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday.

An infographic on DENTSPLY SIRONA's fourth quarter 2018 earnings results
DENTSPLY SIRONA Q4 2018 Earnings Infographic

At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above the forecast. A 4.6% revenue growth in Europe and a 1.4% gain in rest of the world were eclipsed by a 14.7% contraction in the US amid hectic destocking by dealers.

Among the product categories, Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the company’s European distribution center. Meanwhile, Technology & Equipment revenue fell by 7.4%.

Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the European distribution center

Adjusted earnings dropped to $0.58 per share during the three-month period from $0.82 per share in the fourth quarter of 2017. Reported profit was $1.8 million or $0.01 per share, compared to a loss of $650.4 million or $2.85 share in the year-ago quarter.

Related: Dentsply Q3 2018 Earnings Conference Call Transcript

“We have completed a top to bottom diagnostic of the Company and are executing a major restructuring plan to accelerate growth, improve margins and simplify our business,” said CEO Don Casey.

For fiscal 2019, the management expects adjusted earnings in the range of $2.25 per share to $2.40 per share, which represents a 12-19% annual growth. The forecast for full-year reported revenue is $3.95-$4.05 billion. The top line will be negatively impacted by the ongoing portfolio shaping initiatives and unfavorable exchange rates.

Also read: Johnson & Johnson buys Auris Health

Internal sales are estimated to grow between 4% and 5% this year, benefitting from new product launches and the absence of dealer destocking. Going forward, the efforts to simplify the organizational structure, such as consolidation of the dental product groups and regional commercial groups, are expected to strengthen performance.

Shares of Dentsply surged about 8% in the pre-market hours Friday following the earnings report, after closing the previous session higher. Since the beginning of 2019, the stock gained more than 10%.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top